Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1024917 | 0.75 | — | — | |
| SCHEMBL11530245 | 0.75 | — | — | |
| SCHEMBL8567751 | 0.73 | — | — | |
| SCHEMBL1392503 | 0.71 | — | — | |
| SCHEMBL3393602 | 0.71 | KDM4E (0.32) | — | |
| SCHEMBL15991986 | 0.71 | HPGD (0.36) | CYP3A4 | |
| SCHEMBL5917285 | 0.71 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL2238360 | 0.71 | CYP3A4 (0.32) | CYP3A4 | |
| SCHEMBL10566551 | 0.69 | — | — | |
| SCHEMBL1906356 | 0.68 | AHR (0.48) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957632-B | Glycolic acid modified unsaturated polymer and preparation method and application thereof | 华润化学材料科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| US-20230296983-A1 | PHOTOSENSITIVE POLYMER, PHOTORESIST COMPOSITION INCLUDING THE SAME, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-21 | — | — | US | claimed |
| CN-106232120-B | Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2- (1H) -ones | 爱尔皮奥治疗有限公司 | 2021-01-08 | — | — | CN | claimed |
| WO-2020079669-A1 | FUNCTIONALIZED PRODUCT FABRICATED FROM A RESIN COMPRISING A FUNCTIONAL COMPONENT AND A POLYMERIC RESIN, AND METHOD OF MAKING THE SAME | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2020-04-23 | — | — | WO | claimed |
| CN-109651331-A | A kind of glaucocalyxin A derivative and its preparation method and application | 中国人民解放军军事科学院军事医学研究院 | 2019-04-19 | — | — | CN | claimed |
| EP-3408345-A1 | TRACER AND METHOD | Johnson Matthey Public Limited Company (GB) | 2018-12-05 | — | — | EP | claimed |
| WO-2017129944-A1 | TRACER AND METHOD | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2017-08-03 | — | — | WO | claimed |
| US-20170079954-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | AXIKIN PHARMACEUTICALS, INC. | 2017-03-23 | — | — | US | claimed |
| US-9540351-B2 | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors | AXIKIN PHARMACEUTICALS, INC. (US) | 2017-01-10 | — | — | US | claimed |
| EP-3107542-A1 | PROCESS FOR PREPARING N-BENZYL-3-HYDROXY-4-SUBSTITUTED-PYRIDIN-2-(1H)-ONES | Aerpio Therapeutics, Inc. (US) | 2016-12-28 | — | — | EP | claimed |
| US-4226761-A | Polyphenylene ether resin compositions containing polysiloxane-modified alkenyl aromatic resins | GENERAL ELECTRIC COMPANY (US) | 1980-10-07 | — | — | US | claimed |
| US-4208342-A | Polyethylene silicon compounds | RHONE-POULENC INDUSTRIES (FR) | 1980-06-17 | — | — | US | claimed |
| US-4145508-A | Polysiloxane thermoplastic elastomers | RHONE-POULENC INDUSTRIES (FR) | 1979-03-20 | — | — | US | claimed |
| US-4138349-A | FOR LUBRICATING SOFT METALS SUCH AS COPPER OR BRONZE | GENERAL ELECTRIC COMPANY (US) | 1979-02-06 | — | — | US | claimed |
| US-4102893-A | Process for the manufacture of color formers of indoles and anhydrides of aromatic or heteroaromatic, vicinal dicarboxylic acids, new color formers of these classes of substance and their use | CIBA-GEIGY AG (CH) | 1978-07-25 | — | — | US | claimed |
| US-4071316-A | Silicone composition for analyzing blood samples | GENERAL ELECTRIC COMPANY (US) | 1978-01-31 | — | — | US | claimed |
| US-4060623-A | 1,2,4-Triazole antimycotic compositions and use thereof | BAYER AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | claimed |
| US-4038404-A | 1,2,4-TRIAZOLE ANTIMYCOTIC COMPOSITIONS AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-26 | — | — | US | claimed |
| US-4036966-A | 1,2,4-Triazole antimycotic compositions and use thereof | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | claimed |
| US-4036967-A | 1,2,4-Triazole antimycotic compositions and use thereof | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170079954-A1 | PHARMACEUTICALLY ACCEPTABLE SALTS OF 3,5-DIAMINOPYRAZOLE KINASE INHIBITORS | GRK3, DMPK, PRKAG3 | CYP3A4 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.